Showing results (661-670 of 7,629) with videos related to

Sort By:
Pageof 763
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.
American Journal of Hematology|May 1, 2014
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institutionGuilin Tang, Liping Zhang, Bin Fu, et al.
American Journal of Hematology|March 27, 2014
Single agent lenalidomide three times a week induces hematologic responses in AL amyloidosis patients on dialysisEben I Lichtman, David C Seldin, Anthony Shelton, et al.
American Journal of Hematology|March 29, 2014
Chromogenic factor VIII activity assayKaren A Moser, Dorothy M Adcock Funk
American Journal of Hematology|April 9, 2014
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-upCarlo Gambacorti-Passerini, Tim H Brümmendorf, Dong-Wook Kim, et al.
American Journal of Hematology|April 9, 2014
Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphomaHugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
American Journal of Hematology|April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cellsClive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
American Journal of Hematology|October 1, 1989
Resolution of pure red cell aplasia and lymphoma: response to intravenous gammaglobulin and combination chemotherapyS J Vukelja, J Krishnan, C M Link, et al.
American Journal of Hematology|October 1, 1989
Durable remission of pure red cell aplasia after treatment with high-dose intravenous gammaglobulin and prednisoneS W Needleman
American Journal of Hematology|October 1, 1989
Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantationB H Davis, N Bigelow, E D Ball, et al.
Pageof 763